Your browser doesn't support javascript.
loading
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang, Nicholas J; Beer, Tomasz M; Gerritsen, Winald; Oudard, Stéphane; Wiechno, Pawel; Kukielka-Budny, Bozena; Samal, Vladimir; Hajek, Jaroslav; Feyerabend, Susan; Khoo, Vincent; Stenzl, Arnulf; Csöszi, Tibor; Filipovic, Zoran; Goncalves, Frederico; Prokhorov, Alexander; Cheung, Eric; Hussain, Arif; Sousa, Nuno; Bahl, Amit; Hussain, Syed; Fricke, Harald; Kadlecova, Pavla; Scheiner, Tomas; Korolkiewicz, Roman P; Bartunkova, Jirina; Spisek, Radek.
Afiliação
  • Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas.
  • Beer TM; US Oncology Research, The Woodlands, Texas.
  • Gerritsen W; Oregon Health & Science University, Portland.
  • Oudard S; Radboud UMC, Nijmegen, the Netherlands.
  • Wiechno P; Georges Pompidou European Hospital, University of Paris, Paris, France.
  • Kukielka-Budny B; Oncology Center-Institute Marii Sklodowskiej-Curie, Warszawa, Poland.
  • Samal V; Center of Oncology of the Lublin Region St Jana z Dukli, Lublin, Poland.
  • Hajek J; Regional Hospital Liberec, Liberec, Czechia.
  • Feyerabend S; Faculty of Medicine in Hradec Kralove, Charles University, Czechia.
  • Khoo V; University Hospital Ostrava, Ostrava, Czechia.
  • Stenzl A; Studienpraxis Urologie, Nuertingen, Germany.
  • Csöszi T; Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Filipovic Z; University Clinic of Urology, Tuebingen, Germany.
  • Goncalves F; Geza Hetenyi Hospital in Szolnok, Szolnok, Hungary.
  • Prokhorov A; University Hospital Medical Center Bezanijska Kosa, Belgrade, Serbia.
  • Cheung E; CUIMED, Bratislava, Slovakia.
  • Hussain A; Minsk City Oncological Dispensary, Minsk, Belarus.
  • Sousa N; Oncology Institute of Hope and Innovation, Long Beach, California.
  • Bahl A; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.
  • Hussain S; Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.
  • Fricke H; Bristol Haematology and Oncology Centre, Bristol, United Kingdom.
  • Kadlecova P; University of Sheffield, Sheffield, United Kingdom.
  • Scheiner T; SOTIO a.s., Prague, Czechia.
  • Korolkiewicz RP; SOTIO a.s., Prague, Czechia.
  • Bartunkova J; SOTIO a.s., Prague, Czechia.
  • Spisek R; SOTIO a.s., Prague, Czechia.
JAMA Oncol ; 8(4): 546-552, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35142815
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Oncol Ano de publicação: 2022 Tipo de documento: Article